EUVIMEDEUVIMED entdecken
Crossref

Dincharya- (Pratimarsha Nasya) in Allergic Rhinitis: An Integrative Community Health Perspective

Dr. Manisha Shailesh Irali, Dr. Sujata Mukesh Phalke

Intemed International Journal of Research in Integrated Medical Sciences (IJ-RIMS) · 05.11.2026 · 2 (10)

DOI: 10.68108/intemed.v2.i10.14 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Intemed International Journal of Research in Integrated Medical Sciences (IJ-RIMS), online erschienen am 05.11.2026. Verfasst von Dr. Manisha Shailesh Irali und 1 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allergic Rhinitis (AR) presents a widespread immunologic and public health challenge characterized by chronic inflammation of the nasal mucosa, paroxysmal sneezing, rhinorrhea, and nasal congestion. In chronic conditions allergic rhinitis may end up with nasal polyposis. In classical Ayurvedic literature, AR correlates closely with Vataja and Kapha-Vataja Pratishyaya, originating from impaired metabolic fire (Agni), accumulation of metabolic toxins (Ama), and seasonal/daily doshic fluctuations. While conventional pharmacotherapy relies heavily on reactive H1-antihistamines and intranasal corticosteroids, preventive daily health regimens (Dincharya)—specifically low-dose daily nasal oil administration (Pratimarsha Nasya)—offer a sustainable, non-invasive barrier and immunomodulatory intervention. Aim and Objective: To systematically evaluate the biophysical, immunomodulatory, and public health dimensions of incorporating Pratimarsha Nasya into seasonal health awareness strategies for preventing and managing allergic rhinitis at the community primary care level.

Methods

A comprehensive review of classical Ayurvedic treatises (Charaka Samhita, Ashtanga Hridaya) alongside modern literature on nasal mucosal physiology, local drug delivery, and seasonal epidemiology was conducted. Clinical parameters evaluated include mucosal barrier function, ciliary beat frequency, Ig E-mediated mast cell stabilization, and patient treatment compliance.

Results

Pratimarsha Nasya using lipophilic vehicles (e.g., Anu Taila or processed sesame oil) functions through a dual mechanism: (1) creating a physical lipophilic barrier that prevents allergen binding to Ig E receptors on mucosal mast cells, and (2) conditioning the Schneiderian membrane to preserve optimal mucociliary clearance. Integration into community health models via pre-seasonal Ritu Sandhi transition alerts demonstrates a 70–80% reduction in morning sneezing frequency, lower acute clinic visits, and decreased reliance on long-term rescue antihistamines.

Conclusion

Daily Pratimarsha Nasya embedded within Dincharya and aligned with Ritucharya provides a cost-effective, biophysically sound, and scalable preventive framework for allergic rhinitis.

Zitieren

APA

Irali, D. M. S., & Phalke, D. S. M. (2026). Dincharya- (Pratimarsha Nasya) in Allergic Rhinitis: An Integrative Community Health Perspective. Intemed International Journal of Research in Integrated Medical Sciences (IJ-RIMS), 2(10). https://doi.org/10.68108/intemed.v2.i10.14

Vancouver

Irali DMS, Phalke DSM. Dincharya- (Pratimarsha Nasya) in Allergic Rhinitis: An Integrative Community Health Perspective. Intemed International Journal of Research in Integrated Medical Sciences (IJ-RIMS). 2026;2(10). doi:10.68108/intemed.v2.i10.14

BibTeX
@article{Irali2026,
  author = {Irali, Dr. Manisha Shailesh and Phalke, Dr. Sujata Mukesh},
  title = {Dincharya- (Pratimarsha Nasya) in Allergic Rhinitis: An Integrative Community Health Perspective},
  journal = {Intemed International Journal of Research in Integrated Medical Sciences (IJ-RIMS)},
  year = {2026},
  volume = {2},
  number = {10},
  doi = {10.68108/intemed.v2.i10.14}
}
Kostenlos starten →